Sienna Cancer Diagnostics Limited reported consolidated earnings results for the half year ended December 31, 2018. For the year, the company reported revenue was AUD 274,917 against AUD 267,826 a year ago. Total comprehensive loss for the half-year was AUD 901,323 against AUD 1,379,482 a year ago. Basic loss per share was 0.00 cents against 0.01 cents a year ago.